Abiopharma

News list

Heery Christopher 🟡 adjusted position in 6.9K shares of Arcellx, Inc. (ACLX) at $64.15 Transaction Date: Jan 12, 2026 | Filing ID: 010889

Full text

News bot Jan. 13, 2026, 2:33 a.m.
🔍 Heery Christopher (Executive)

Company: Arcellx, Inc. (ACLX)

Report Date: 2026-01-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 13,021
- Total shares sold: 6,131
Detailed Transactions and Holdings:
- Acquired 13,021 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: M | equity_swap_involved: false | shares_owned_after: 13,615.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 6,131 shares of Common Stock at $64.1471 per share (Direct)
  Date: 2026-01-12 | Code: S | equity_swap_involved: false | shares_owned_after: 37,068.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Vesting of these RSUs previously reported in the Form 4 filed January 6, 2026.
- F2: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- F3: Represents the weighted average share price of an aggregate total of 6,131 shares sold in the price range of $64.14112 to $64.4463 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.